Ovestin

Medicinal product

(Invented) name

Ovestin

Active substance (s)

Estriolis

Strength

0,5 mg

Pharmaceutical form

ovulės

Route (s) of administration

vartoti į makštį

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

G03CA04, Estriol

Marketing authorisation holder

UAB Lex ano, Lietuva

Date of authorisation

2025-03-07

Date of renewal

Documents

2414_Ovestin 0,5 mg ovulės_PL_2025-03-07.docx

2414_Ovestin 0,5 mg ovulės_PZ_2025-03-07.docx

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

Procedure number

Marketing authorisation procedure

Lygiagretus importas

Qualitative and quantitative composition

Ovulėje yra:	1 vnt.
Estriolis	0,5 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
116917	103021	1103021	lizdinė plokštelė	N15		Receptinis	LT/L/25/2414/001	Tiekiama	2025-07-01	-	No	-	-	Download

Stadijos

Data	Stadija
2025-03-07	Registruotas